|1st December 2020||Joshua Silverman||100,000||Sale back to the issuer||$0.00|
|1st December 2020||Joshua Silverman||20,000||Grant/award etc.||$0.00|
|2nd November 2020||Bay Capital Management Lp Hudson||50,000||Open or private sale||$10.87||$543,500.00|
|16th October 2020||Joshua Silverman||50,000||Open or private purchase||$1.09||$54,445.00|
|16th October 2020||Bay Capital Management Lp Hudson||1,601,100||Other acquisition or disposition||$10.30||$16,491,330.00|
|15th October 2020||Joshua Silverman||50,000||Open or private purchase||$1.07||$53,315.00|
|28th August 2020||Bay Capital Management Lp Hudson||340,000||Other acquisition or disposition||$10.77||$3,661,800.00|
|13th July 2020||Bay Capital Management Lp Hudson||346,857||Open or private sale||$10.88||$3,773,804.16|
|10th July 2020||Bay Capital Management Lp Hudson||13,143||Open or private sale||$10.92||$143,521.56|
|6th July 2020||Billy Joe White||212,131||Exercise of derivative||$1.15||$243,950.65|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.
Akers Biosciences, Inc. develops health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products. The company was founded by Raymond Francis Akers, Jr. and Raymond F.Akers, Sr. on March 8, 1989.